# Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test.

> **NCT02064699** · — · TERMINATED · sponsor: **University Hospital, Limoges** · enrollment: 75 (actual)

## Conditions studied

- Renal Transplant Recipient
- Immunized Against the Cytomegalovirus

## Interventions

- **BIOLOGICAL:** CMV Infection

## Key facts

- **NCT ID:** NCT02064699
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-05
- **Primary completion:** 2017-12-13
- **Final completion:** 2017-12-13
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02064699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02064699, "Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02064699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*